share_log
Benzinga ·  05/02 12:06

Elavi Labs Shares Are Trading Higher After the Company Announced the Launch of Elevai Biosciences and Elevai Skincare. Also, the Company Announced Results From Its Licensor's 2022 Preclinical Studies Evaluating the Treatment Effect of EL-22

在該公司宣佈推出Elevai Biosciences和Elevai Skincare之後,該公司股價走高。此外,該公司還公佈了其許可方2022年評估 EL-22 治療效果的臨床前研究結果

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論